Recombinant Erythropoietin Market Is Estimated To Witness High Growth Owing To Growing Demand for Anemia Treatment and Increasing Adoption of Biosimilar Erythropoietin
The global recombinant erythropoietin market is estimated to be valued at US$ 7.01 billion in 2023 and is expected to exhibit a CAGR of 2% …